1. Genius Group initiates legal action against major brokerages for restricting buy orders. 2. Investors report difficulties buying GNS shares, causing sell-side trading imbalance. 3. CEO states broker actions suppress legitimate demand, impacting stock prices negatively. 4. Legal team argues brokers violate fair trading access under U.S. securities law. 5. The company emphasizes that buy-sell imbalance distorts natural price formation.
FAQ
Why Bullish?
Legal action may compel changes benefiting buy-side interest, improving demand dynamics.
How important is it?
The legal action is crucial; it may restore buy functionality, enhancing investor access.
Why Short Term?
Immediate legal proceedings could lead to swift changes affecting trading conditions.
Genius Group Takes Legal Action to Restore Buy Button Functionality for GNS Shares
SINGAPORE, Dec. 02, 2025 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS), an innovative AI-powered, Bitcoin-first education enterprise, has announced it is pursuing legal action against several major brokerage firms to restore the ability for investors to purchase shares of GNS online.
Overview of Legal Action
Genius Group has engaged The Basile Law Firm P.C. in response to complaints from numerous investors that brokerage firms, including Charles Schwab & Co., Inc., Fidelity Global Brokerage Group, Inc., The Vanguard Group, Inc., and Robinhood Markets, Inc., have made it significantly more challenging to buy shares of GNS than to sell them. This disparity has created a sell-side imbalance in the trading of GNS shares.
In an effort to resolve these issues, Genius Group sent Demand Notices to all implicated parties on November 16, 2025, requesting the immediate reinstatement of full buy functionality for GNS shares. With no compliance from the brokerage firms, the Company has decided to take further legal steps.
Statements from Leadership
Roger James Hamilton, CEO of Genius Group, emphasized the stakes involved: “When a broker makes it harder to buy than to sell a stock for an extended period, it creates a one-sided market that artificially pressures the price downward.” He noted that this manipulation hinders legitimate demand and amplifies selling pressure, potentially causing long-term harm to both investors and the Company.
Mark R. Basile, Esq. of The Basile Law Firm P.C., highlighted the legal precedents and implications of the matter. He stated, “The SEC and FINRA require broker-dealers to uphold fair dealing, best execution, and non-discriminatory access to trading.” He warned that the restriction of buy orders could lead to a violation of anti-manipulation rules and undermine market integrity.
Regulatory Context and Implications
The actions being taken by Genius Group revolve around the adherence to several regulatory frameworks, including:
- Regulation NMS Rule 611 - Order Protection Rule, mandating fair access to trading.
- FINRA Rule 5310 - Best Execution, requiring brokers to provide optimal trade execution.
- Exchange Act - Demands non-discriminatory access to trading platforms.
Basile pointed out that a trading platform that restricts buying while facilitating selling can be seen as a manipulative device, which contravenes the directives outlined in the Exchange Act.
Background on Genius Group
Genius Group (NYSE: GNS) is a pioneering enterprise focused on AI-driven educational solutions, catering to over 6 million users across more than 100 countries. The Company operates through its Genius City model and a digital marketplace that integrates AI training, tools, and talent, delivering tailored pathways that combine human capability with AI innovations.
To learn more about Genius Group's initiatives, visit their official website at geniusgroup.ai.
About The Basile Law Firm P.C.
The Basile Law Firm P.C. specializes in complex securities litigation and represents public companies and shareholders in disputes involving brokers and other financial institutions. The firm is currently assisting Genius Group in various legal matters, including arbitration and lawsuits aimed at safeguarding the interests of the Company and its investors.